Matthew Mace on Study Connect, Why Pharma Needs MedTech Outsiders in Cardiology | Pharma Prescribed
Matthew Mace — founder of Study Connect, host of the Study Success Podcast and board director at Precision Cardiovascular — joins Adam Walker for one of the most energetic conversations on the Pharma Prescribed Podcast.
Matt isn't from pharma. He comes from MedTech, cardiovascular devices and cardiology innovation. As co-founder and CSO at Acharai, he led the largest hemodynamic study in heart failure history, secured FDA breakthrough device designation and raised over $10M. Now he's building Study Connect — a platform to streamline collaboration between investigators and sponsors — while serving on the board at Precision Cardiovascular.
He also runs marathons, does Ironmans and never misses Saturday morning daddy-daughter time.
🎧 LISTEN ON YOUR PREFERRED APP
Spotify → https://open.spotify.com/episode/1GIdsiPgFjsykGyzFPPvRk?si=4erLYiySS8mgS80tVziGsQ
Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-matthew-mace-founder-of/id1829715970?i=1000719640597
Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
Podbean → https://www.podbean.com/eas/pb-su9t6-19186e9
📖 WHAT WE COVER
- MedTech outsider looking in: what pharma gets wrong about collaboration
- The largest hemodynamic study in heart failure history
- FDA breakthrough device designation and raising $10M
- Study Connect: beta testing the platform with physicians
- Why investigators don't want another portal — they want connection
- The Study Success Podcast and why Matt started it
- Marathons, Ironman and the 85-year-old doing all seven majors
- Saturday morning daddy-daughter time at the play park
- Do the right thing, be honest — the golden rule
⏱️ CHAPTERS
0:00 Introduction & podcast mission
1:00 Meet Matthew Mace — founder of Study Connect
2:00 "I come with a warning — I'm non-pharma pretending I know about trials"
3:00 Study Connect beta launch and physician feedback
5:00 15 years in cardiology, AI and MedTech
8:00 Acorai: the largest hemodynamic study in heart failure
12:00 FDA breakthrough device and raising $10M
16:00 Study Connect: what the platform actually does
20:00 Universal problems across CROs, sponsors and tech companies
24:00 Why investigators need connection, not another portal
28:00 Precision Cardiovascular and next-gen monitoring
32:00 Marathons, Ironman and the grandfather who ran for GB
36:00 Saturday mornings, Asa and daddy-daughter time
38:00 Quick-fire: honesty and doing the right thing
40:00 studyconnect.world — and the chatbot that goes straight to Matt's inbox
👤 ABOUT MATTHEW MACE
Founder of Study Connect. Host of the Study Success Podcast. Board director at Precision Cardiovascular. Former CSO at Acharai. 15+ years in cardiology, AI and MedTech.
🌐 https://www.studyconnect.world
💼 Search "Matthew Mace" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBED
Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
🌐 https://pharmaprescribed.com
💼 https://www.linkedin.com/in/adam-walker-2327951/
#MatthewMace #StudyConnect #StudySuccessPodcast #PrecisionCardiovascular #PharmaPrescribed #AdamWalker #MedTech #Cardiology #HeartFailure #FDABreakthrough #ClinicalTrials #LifeSciences #Ironman #Marathon #InvestigatorEngagement
